Britton Trabert

Britton Trabert, MS, MSPH, PhD

Languages spoken: English

Academic Information

Departments Primary - Obstetrics & Gynecology , Adjunct - Population Health Sciences

Divisions: Gynecological Oncology

Research Interests

  • Ovarian Cancer
  • Endometrial Cancer
  • Cancer Survivorship
  • Etiologic Heterogeneity

Britton Trabert, MS, PhD is a reproductive and cancer epidemiologist and Associate Professor of Obstetrics and Gynecology at the University of Utah School of Medicine, Adjunct Associate Professor of Population Health Sciences at the University of Utah School of Medicine, and a Huntsman Cancer Institute Investigator in the Cancer Control and Population Sciences Research Program. Dr. Trabert received her BS in Biology from Iowa State University, an MSPH in Epidemiology from the Rollins School of Public Health at Emory University, and an MS in Biostatistics from the University of Michigan School of Public Health where she actively participated in the interdepartmental concentration in Reproductive and Women’s Health. Dr. Trabert completed her doctoral degree in Epidemiology at the University of Washington School of Public Health and was the inaugural predoctoral fellow on the T32 Reproductive, Pediatric, and Perinatal Epidemiology Training Grant. She joined the National Cancer Institute's (NCI) Division of Cancer Epidemiology and Genetics as a Sallie Rosen Kaplan Postdoctoral Fellow in 2009, was promoted to research fellow in 2011, and was appointed as an Earl Stadtman Tenure-Track Investigator in 2014, where she led a multi-disciplinary research program in the Metabolic Epidemiology Branch of the Division of Cancer Epidemiology and Genetics. She has been a member of the Huntsman Cancer Institute and the University of Utah since 2021. Dr. Trabert is co-chair of the Ovarian Cancer Cohort Consortium and co-chair of the Mentoring Committee of the Society for Epidemiologic Research. She is passionate about providing a welcoming and supportive training program and is dedicated to mentoring the next generation of cancer epidemiologists.

Dr. Trabert’s research program addresses critical research questions related to the prevention of gynecologic cancers and integrates pharmacoepidemiology, reproductive epidemiology, and molecular epidemiology to understand cancer risk, etiologic heterogeneity, and progression. Dr. Trabert is PI of Department of Defense Investigator Initiated Research Award's in the Ovarian Cancer Research Program to evaluate the association between frequent aspirin use and other commonly used medications and ovarian cancer risk.

Education History

Research Fellow National Institutes of Health, National Cancer Institute
 Postdoctoral Senior Research Fellow
Postdoctoral Fellowship National Institutes of Health, National Cancer Institute
 Postdoctoral Fellow
Fellowship University of Washington
 Predoctoral Fellow
Professional Medical University of Washington
 PhD
Graduate Training University of Michigan
 MS
Graduate Training Emory University
 MSPH
Undergraduate Iowa State University
 BS

Selected Publications

Journal Article

  1. OConnell CP, Hong HG, Abar L, Khandpur N, Martnez Steele E, Liao LM, Sinha R, Trabert B, Loftfield E (2025). Ultra-processed food intake and risk of ovarian and endometrial cancer in the NIH-AARP cohort: a prospective cohort analysis: Ultra-processed food, ovarian & endometrial cancer. Am J Clin Nutr. (Read full article)
  2. Lozano-Esparza S, Unar-Mungua M, Trabert B, Gmez-Flores-Ramos L, Brochier M, Hernndez-vila JE, Stern D, Lajous M (2025). Lifetime breastfeeding and mortality among parous women in the Mexican Teacher's Cohort. Int J Gynaecol Obstet. (Read full article)
  3. Madrigal JM, Trabert B, Medgyesi DN, Fisher JA, Calafat AM, Cook Botelho J, Kato K, Albert PS, Silverman DT, Hofmann JN, Jones RR (2025). Pre-diagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of endometrial cancer in a US cohort. Environ Health Perspect. (Read full article)
  4. Stern D, Gomez-Flores-Ramos L, Trabert B, Setiawan VW, Le Marchand L, Gomez H, Scheet PA, Parada H Jr, Pirzada A, Lajous M, Farland LV (2025). Leveraging existing cohort studies of Mexican women to better understand Hispanic health and cancer risk. Cancer Causes Control. (Read full article)
  5. Thomson CA, Basen-Engquist K, Robles-Morales R, Roe DJ, Erdrich J, Trabert B, Saquib N, Cote ML, Qi L, Lane DS, Crane TE (2025). Epidemiological Analysis of Obesity-related co-morbidities and mortality among post- menopausal women diagnosed with endometrial cancer: A Randomized Controlled Trial. Res Sq. (Read full article)
  6. Meade CE, Sinnott JA, Padamsee TJ, Clarke MA, Plascak JJ, Cosgrove CM, Trabert B, Felix AS (2025). Geographic Variation of Racial and Ethnic Differences in Uterine Cancer Survival. JAMA Netw Open, 8(4), e257227. (Read full article)
  7. Nagle CM, Ibiebele TI, Na R, Bandera EV, Cramer D, Doherty JA, Giles GG, Goodman MT, Hanley GE, Harris HR, Jensen A, Kjaer SK, Lee A, McGuire V, Milne RL, Qin B, Richardson J, Sasamoto N, Schildkraut JM, Sieh W, Terry KL, Titus L, Trabert B, Wentzensen N, Wu AH, Berchuck A, Pike MC, Pearce CL, Webb PM, Multidisciplinary Ovarian Cancer Outcomes Group and Ovarian Cancer Association Consortium (2025). Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium. Am J Clin Nutr, 121(4), 758-768. (Read full article)
  8. Carey AB, Meade CE, Trabert B, Cosgrove CM, Felix AS (2025). Determinants of first-line clinical trial enrollment among Black and White gynecologic cancer patients. Cancer Causes Control. (Read full article)
  9. Khadraoui W, Sinnott JA, Meade CE, Plascak J, Carey A, Backes FJ, Dood RL, Trabert B, Felix AS (2024). Clinical trial enrollment during first course of gynecologic cancer treatment and survival. Gynecol Oncol, 192, 59-64. (Read full article)
  10. McCarty RD, Trabert B, Kriebel D, Millar MM, Birmann BM, Grieshober L, Barnard ME, Collin LJ, Lawson-Michod KA, Gibson B, Sawatzki J, Carter M, Yoder V, Gilreath JA, Shami PJ, Doherty JA (2024). Tattoos and Risk of Hematologic Cancer: A Population-Based Case-Control Study in Utah. Cancer Med, 13(20), e70260. (Read full article)
  11. Kitahara CM, Surcel HM, Falk R, Pfeiffer RM, Mnnist T, Gissler M, Trabert B (2024). Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort. Int J Cancer, 155(6), 1014-1022. (Read full article)
  12. McCarty RD, Trabert B, Millar MM, Kriebel D, Grieshober L, Barnard ME, Collin LJ, Lawson-Michod KA, Gibson B, Gilreath JA, Shami PJ, Doherty JA (2024). Associations of demographic, health, and risk-taking behaviors with tattooing in a population-based cross-sectional study of ~18,000 US adults. Res Sq. (Read full article)
  13. Nagle CM, Ibiebele TI, Bandera EV, Cramer D, Doherty JA, Giles GG, Goodman MT, Hanley GE, Harris HR, Jensen A, Kjaer SK, Lee AW, Milne RL, Qin B, Richardson J, Sasamoto N, Sieh W, Terry KL, Titus L, Trabert B, Wentzensen N, Wu AH, Berchuck A, Pike M, Pearce CL, Webb PM (2024). Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer, 131(6), 1043-1049. (Read full article)
  14. Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC (2024). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482-489. (Read full article)
  15. Sasamoto N, Hathaway CA, Townsend MK, Terry KL, Trabert B, Tworoger SS (2024). Prospective analysis of circulating biomarkers and ovarian cancer risk in the UK Biobank. Cancer Epidemiol Biomarkers Prev. (Read full article)
  16. Meade CE, Sinnott JA, Backes FJ, Cosgrove CM, Quick AM, Trabert B, Plascak JJ, Felix AS (2024). Associations between race and ethnicity and treatment setting among gynecologic cancer patients. Gynecol Oncol, 188, 111-119. (Read full article)
  17. Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, Dezem FS, Seo JH, Nameki R, Reyes AL, Aben KKH, Anton-Culver H, Antonenkova NN, Aravantinos G, Bandera EV, Beane Freeman LE, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bernardini MQ, Bjorge L, Black A, Bogdanova NV, Bolton KL, Brenton JD, Budzilowska A, Butzow R, Cai H, Campbell I, Cannioto R, Chang-Claude J, Chanock SJ, Chen K, Chenevix-Trench G, AOCS Group, Chiew YE, Cook LS, DeFazio A, Dennis J, Doherty JA, Drk T, du Bois A, Drst M, Eccles DM, Ene G, Fasching PA, Flanagan JM, Fortner RT, Fostira F, Gentry-Maharaj A, Giles GG, Goodman MT, Gronwald J, Haiman CA, Hkansson N, Heitz F, Hildebrandt MAT, Hgdall E, Hgdall CK, Huang RY, Jensen A, Jones ME, Kang D, Karlan BY, Karnezis AN, Kelemen LE, Kennedy CJ, Khusnutdinova EK, Kiemeney LA, Kjaer SK, Kupryjanczyk J, Labrie M, Lambrechts D, Larson MC, Le ND, Lester J, Li L, Lubiski J, Lush M, Marks JR, Matsuo K, May T, McLaughlin JR, McNeish IA, Menon U, Missmer S, Modugno F, Moffitt M, Monteiro AN, Moysich KB, Narod SA, Nguyen-Dumont T, Odunsi K, Olsson H, Onland-Moret NC, Park SK, Pejovic T, Permuth JB, Piskorz A, Prokofyeva D, Riggan MJ, Risch HA, Rodrguez-Antona C, Rossing MA, Sandler DP, Setiawan VW, Shan K, Song H, Southey MC, Steed H, Sutphen R, Swerdlow AJ, Teo SH, Terry KL, Thompson PJ, Vestrheim Thomsen LC, Titus L, Trabert B, Travis R, Tworoger SS, Valen E, Van Nieuwenhuysen E, Edwards DV, Vierkant RA, Webb PM, OPAL Study Group, Weinberg CR, Weise RM, Wentzensen N, White E, Winham SJ, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Zeinomar N, Zheng W, Ziogas A, Berchuck A, Goode EL, Huntsman DG, Pearce CL, Ramus SJ, Sellers TA, Ovarian Cancer Association Consortium OCAC, Freedman ML, Lawrenson K, Schildkraut JM, Hazelett D, Plummer JT, Kar S, Jones MR, Pharoah PDP, Gayther SA (2024). Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. Am J Hum Genet, 111(6), 1061-1083. (Read full article)
  18. Davis EW, Attwood K, Prunier J, Paragh G, Joseph JM, Klein A, Roche C, Barone N, Etter JL, Ray AD, Trabert B, Schabath MB, Peres LC, Cannioto R (2024). The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality. J Natl Cancer Inst. (Read full article)
  19. Geczik AM, Michels KA, Anderson GL, Falk RT, Farland LV, Manson JE, Shadyab AH, Pfeiffer RM, Xu X, Trabert B (2024). Associations of tubal ligation and hysterectomy with serum androgen and estrogen metabolites among postmenopausal women in the Women's Health Initiative Observational Study. Cancer Causes Control. (Read full article)
  20. Abril J, Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, Glimelius I, Madanat-Harjuoja L, Gulbech Ording A, Srensen HT, Tretli S, Bjrge T (2023). Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case-control study. Cancer Causes Control, 35(5), 741-747. (Read full article)
  21. Shailendra P, Baldock KL, Li LSK, Gorzelitz J, Matthews CE, Trabert B, Bennie JA, Boyle T (2023). Weight training and risk of all-cause, cardiovascular disease and cancer mortality among older adults. Int J Epidemiol, 53(3). (Read full article)
  22. Frias-Gomez J, Alemany L, Benavente Y, Clarke MA, de Francisco J, De Vivo I, Du M, Goodman MT, Lacey J, Liao LM, Lipworth L, Lu L, Merritt MA, Michels KA, OConnell K, Paytubi S, Pelegrina B, Peremiquel-Trillas P, Petruzella S, Ponce J, Risch H, Setiawan VW, Schouten LJ, Shu XO, Trabert B, Van den Brandt PA, Wentzensen N, Wilkens LR, Yu H, Costas L (2023). Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Sleep Med Rev, 72, 101848. (Read full article)
  23. Wu Z, Trabert B, Guillemette C, Caron P, Bradwin G, Graubard BI, Weiderpass E, Ursin G, Langseth H, McGlynn KA (2023). Pre-diagnostic hormone levels and risk of testicular germ cell tumors: a nested case-control study in the Janus Serum Bank. Cancer Epidemiol Biomarkers Prev. (Read full article)
  24. Hathaway CA, Townsend MK, Sklar EM, Thomas-Purcell KB, Terry KL, Trabert B, Tworoger SS (2023). The Association of Kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk. Cancer Epidemiol Biomarkers Prev. (Read full article)
  25. Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, Pharoah PDP, Qin B, Terry KL, Titus LJ, Webb PM, Australian Ovarian Cancer Study Group, Wu AH, Zeinomar N, Ziogas A, Berchuck A, Cho KR, Hanley GE, Meza R, Mukherjee B, Pike MC, Pearce CL, Trabert B, Ovarian Cancer Association Consortium (2023). A framework for assessing interactions for risk stratification models: the example of ovarian cancer. J Natl Cancer Inst, 115(11), 1420-1426. (Read full article)
  26. Wu Z, Pfeiffer RM, Byrd DA, Wan Y, Ansong D, Clegg-Lamptey JN, Wiafe-Addai B, Edusei L, Adjei E, Titiloye N, Dedey F, Aitpillah F, Oppong J, Vanderpuye V, Osei-Bonsu E, Dagnall CL, Jones K, Hutchinson A, Hicks BD, Ahearn TU, Knight R, Biritwum R, Yarney J, Wiafe S, Awuah B, Nyarko K, Garcia-Closas M, Sinha R, Figueroa JD, Brinton LA, Trabert B, Vogtmann E (2023). Associations of Circulating Estrogens and Estrogen Metabolites with Fecal and Oral Microbiome in Postmenopausal Women in the Ghana Breast Health Study. Microbiol Spectr, e0157223. (Read full article)
  27. Harvey SV, Wentzensen N, Bertrand K, Black A, Brinton LA, Chen C, Costas L, Dal Maso L, De Vivo I, Du M, Garcia-Closas M, Goodman MT, Gorzelitz J, Johnson L, Lacey JV, Liao L, Lipworth L, Lissowska J, Miller AB, OConnell K, OMara TA, Ou X, Palmer JR, Patel AV, Paytubi S, Pelegrina B, Petruzella S, Prizment A, Rohan T, Sandin S, Setiawan VW, Sinha R, Trabert B, Webb PM, Wilkens LR, Xu W, Yang HP, Zheng W, Clarke MA (2023). Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2). Int J Epidemiol. (Read full article)
  28. Zeleznik OA, Irvin SR, Samimi G, Trabert B (2022). The Role of Statins in the Prevention of Ovarian and Endometrial Cancers. Cancer Prev Res (Phila), 16(4), 191-197. (Read full article)
  29. Romanos-Nanclares A, Tabung FK, Sinnott JA, Trabert B, De Vivo I, Playdon MC, Eliassen AH (2022). Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women. J Natl Cancer Inst, 115(3), 311-321. (Read full article)
  30. Hurwitz LM, Webb PM, Jordan SJ, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Schildkraut JM, Berchuck A, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, Wu AH, Pearce CL, Wentzensen N, Tworoger SS, Pharoah PDP, Trabert B (2023). Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. JAMA Netw Open, 6(2), e230666. (Read full article)
  31. Brasky TM, Hade EM, Cohn DE, Newton AM, Petruzella S, OConnell K, Bertrand KA, Cook LS, De Vivo I, Du M, Freudenheim JL, Friedenreich CM, Goodman MT, Gorzelitz J, Ibiebele TI, Krogh V, Liao LM, Lipworth L, Lu L, McCann S, OMara TA, Palmer JR, Ponte J, Prizment A, Risch H, Sandin S, Schouten LJ, Setiawan VW, Shu XO, Trabert B, van den Brandt PA, Webb PM, Wentzensen N, Wilkens LR, Wolk A, Yu H, Neuhouser ML (2022). Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis. Gynecol Oncol, 169, 137-146. (Read full article)
  32. Shi J, Kraft P, Rosner B, Benavente Y, Black A, Brinton LA, Chen C, Clarke MA, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Frias-Gomez J, Friedenreich CM, Garcia-Closas M, Goodman MT, Johnson L, La Vecchia C, Levi F, Lissowska J, Lu L, McCann SE, Moysich KB, Negri E, OConnell K, Parazzini F, Petruzella S, Polesel J, Ponte J, Rebbeck TR, Reynolds P, Ricceri F, Risch H, Sacerdote C, Setiawan VW, Shu XO, Spurdle AB, Trabert B, Webb PM, Wentzensen N, Wilkens LR, Xu WH, Yang HP, Yu H, Du M, De Vivo I (2023). Risk prediction models for endometrial cancer: development and validation in an international consortium. J Natl Cancer Inst. (Read full article)
  33. Sponholtz TR, Palmer JR, Rosenberg L, Chen C, Chen Y, Clarke MA, Clendenen T, Du M, Johnson L, Liao LM, Michels KA, OConnell K, Olson SH, Petruzella S, Rebbeck TR, Setiawan VW, Trabert B, Weiss NS, Wentzensen N, Wilkens L, Wise LA (2022). Risk factors for endometrial cancer in Black women. Cancer Causes Control. (Read full article)
  34. Medgyesi DN, Trabert B, Fisher JA, Xiao Q, James P, White AJ, Madrigal JM, Jones RR (2022). Outdoor light at night and risk of endometrial cancer in the NIH-AARP diet and health study. Cancer Causes Control, 34, 181-187. (Read full article)
  35. Phung MT, Muthukumar A, Trabert B, Webb PM, Jordan SJ, Terry KL, Cramer DW, Titus LJ, Risch HA, Doherty JA, Harris HR, Goodman MT, Modugno F, Moysich KB, Jensen A, Kjaer SK, Anton-Culver H, Ziogas A, Berchuck A, Khoja L, Wu AH, Pike MC, Pearce CL, Lee AW (2022). Effects of risk factors for ovarian cancer in women with and without endometriosis. Fertil Steril, 118, 960-969. (Read full article)
  36. Gorzelitz J, Trabert B, Katki HA, Moore SC, Watts EL, Matthews CE (2022). Independent and joint associations of weightlifting and aerobic activity with all-cause, cardiovascular disease and cancer mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Sports Med, 56, 1277-1283. (Read full article)
  37. Stang A, Trocchi P, Kajter H, Trabert B, Oosterhuis JW, McGlynn KA (2022). Age-incidence patterns of seminoma and nonseminoma among males and females in Germany and the United States, 2008-2016. Andrology, 11, 65-72. (Read full article)
  38. Crous-Bou M, Du M, Gunter MJ, Setiawan VW, Schouten LJ, Shu XO, Wentzensen N, Bertrand KA, Cook LS, Friedenreich CM, Gapstur SM, Goodman MT, Ibiebele TI, La Vecchia C, Levi F, Liao LM, Negri E, McCann SE, OConnell K, Palmer JR, Patel AV, Ponte J, Reynolds P, Sacerdote C, Sinha R, Spurdle AB, Trabert B, van den Brandt PA, Webb PM, Petruzella S, Olson SH, De Vivo I, Epidemiology of Endometrial Cancer Consortium E2C2 (2022). Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2). Am J Clin Nutr, 116, 1219-28. (Read full article)
  39. Dood RL, Pappas LM, Collin LJ, Vranes C, Trabert B, Doherty JA (2022). Mortality patterns of synchronous uterine and ovarian cancers: a SEER registry analysis. Cancer Epidemiol Biomarkers Prev, 31, 2038-2045. (Read full article)
  40. Hurwitz LM, Townsend MK, Jordan SJ, Patel AV, Teras LR, Lacey JV Jr, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Robien K, Prizment A, Schildkraut JM, Berchuck A, Fortner RT, Chan AT, Wentzensen N, Hartge P, Sandler DP, OBrien KM, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, Pearce CL, Wu AH, White E, Peters U, Webb PM, Tworoger SS, Trabert B (2022). Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. J Clin Oncol, 40, JCO2101900. (Read full article)
  41. Dood R, Trabert B, Werner TL, Gaffney D, Jarboe E (2022). The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers. Int J Gynecol Cancer. (Read full article)
  42. Medgyesi DN, Trabert B, Sampson J, Weyer PJ, Prizment A, Fisher JA, Beane Freeman LE, Ward MH, Jones RR (2022). Drinking Water Disinfection Byproducts, Ingested Nitrate, and Risk of Endometrial Cancer in Postmenopausal Women. Environ Health Perspect, 130(5), 57012. (Read full article)
  43. Geczik AM, Falk RT, Xu X, Ansong D, Yarney J, Wiafe-Addai B, Edusei L, Dedey F, Vanderpuye V, Titiloye N, Adjei E, Aitpillah F, Osei-Bonsu E, Oppong J, Biritwum R, Nyarko K, Wiafe S, Awuah B, Clegg-Lamptey JN, Ahearn TU, Figueroa J, Garcia-Closas M, Brinton LA, Trabert B (2022). Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study. Breast Cancer Res, 24(1), 9. (Read full article)
  44. Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaa J, Bandera EV, Barkardottir RB, Barrowdale D, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bermisheva M, Bernardini MQ, Bjorge L, Black A, Bogdanova NV, Bonanni B, Borg A, Brenton JD, Budzilowska A, Butzow R, Buys SS, Cai H, Caligo MA, Campbell I, Cannioto R, Cassingham H, Chang-Claude J, Chanock SJ, Chen K, Chiew YE, Chung WK, Claes KBM, Colonna S, GEMO Study Collaborators, GC-HBOC Study Collaborators, EMBRACE Collaborators, Cook LS, Couch FJ, Daly MB, Dao F, Davies E, de la Hoya M, de Putter R, Dennis J, DePersia A, Devilee P, Diez O, Ding YC, Doherty JA, Domchek SM, Drk T, du Bois A, Drst M, Eccles DM, Eliassen HA, Engel C, Evans GD, Fasching PA, Flanagan JM, Fortner RT, Machackova E, Friedman E, Ganz PA, Garber J, Gensini F, Giles GG, Glendon G, Godwin AK, Goodman MT, Greene MH, Gronwald J, OPAL Study Group, AOCS Group, Hahnen E, Haiman CA, Hkansson N, Hamann U, Hansen TVO, Harris HR, Hartman M, Heitz F, Hildebrandt MAT, Hgdall E, Hgdall CK, Hopper JL, Huang RY, Huff C, Hulick PJ, Huntsman DG, Imyanitov EN, KConFab Investigators, HEBON Investigators, Isaacs C, Jakubowska A, James PA, Janavicius R, Jensen A, Johannsson OT, John EM, Jones ME, Kang D, Karlan BY, Karnezis A, Kelemen LE, Khusnutdinova E, Kiemeney LA, Kim BG, Kjaer SK, Komenaka I, Kupryjanczyk J, Kurian AW, Kwong A, Lambrechts D, Larson MC, Lazaro C, Le ND, Leslie G, Lester J, Lesueur F, Levine DA, Li L, Li J, Loud JT, Lu KH, Lubiski J, Mai PL, Manoukian S, Marks JR, Matsuno RK, Matsuo K, May T, McGuffog L, McLaughlin JR, McNeish IA, Mebirouk N, Menon U, Miller A, Milne RL, Minlikeeva A, Modugno F, Montagna M, Moysich KB, Munro E, Nathanson KL, Neuhausen SL, Nevanlinna H, Yie JNY, Nielsen HR, Nielsen FC, Nikitina-Zake L, Odunsi K, Offit K, Olah E, Olbrecht S, Olopade OI, Olson SH, Olsson H, Osorio A, Papi L, Park SK, Parsons MT, Pathak H, Pedersen IS, Peixoto A, Pejovic T, Perez-Segura P, Permuth JB, Peshkin B, Peterlongo P, Piskorz A, Prokofyeva D, Radice P, Rantala J, Riggan MJ, Risch HA, Rodriguez-Antona C, Ross E, Rossing MA, Runnebaum I, Sandler DP, Santamaria M, Soucy P, Schmutzler RK, Setiawan VW, Shan K, Sieh W, Simard J, Singer CF, Sokolenko AP, Song H, Southey MC, Steed H, Stoppa-Lyonnet D, Sutphen R, Swerdlow AJ, Tan YY, Teixeira MR, Teo SH, Terry KL, Terry MB, OCAC Consortium, CIMBA Consortium, Thomassen M, Thompson PJ, Thomsen LCV, Thull DL, Tischkowitz M, Titus L, Toland AE, Torres D, Trabert B, Travis R, Tung N, Tworoger SS, Valen E, van Altena AM, van der Hout AH, Van Nieuwenhuysen E, van Rensburg EJ, Vega A, Edwards DV, Vierkant RA, Wang F, Wappenschmidt B, Webb PM, Weinberg CR, Weitzel JN, Wentzensen N, White E, Whittemore AS, Winham SJ, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Zavaglia KM, Zheng W, Ziogas A, Zorn KK, Kleibl Z, Easton D, Lawrenson K, DeFazio A, Sellers TA, Ramus SJ, Pearce CL, Monteiro AN, Cunningham J, Goode EL, Schildkraut JM, Berchuck A, Chenevix-Trench G, Gayther SA, Antoniou AC, Pharoah PDP (2022). Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet, 30, 349-362. (Read full article)
  45. Geczik AM, Falk RT, Xu X, Wiafe-Addai B, Yarney J, Awuah B, Biritwum R, Vanderpuye V, Dedey F, Adjei E, Aitpillah F, Osei-Bonsu E, Oppong J, Titiloye N, Edusei L, Nyarko K, Clegg-Lamptey JN, Wiafe S, Ansong D, Ahearn TU, Figueroa J, Garcia-Closas M, Brinton LA, Trabert B (2022). Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana. J Expo Sci Environ Epidemiol. (Read full article)
  46. King LA, Wentzensen N, Purdue MP, Katki HA, Pinto LA, Trabert B (2021). Inflammatory markers in women with reported benign gynecologic pathology: An analysis of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Ann Epidemiol, 68, 1-8. (Read full article)
  47. Hurwitz LM, Shadyab AH, Tabung FK, Anderson GL, Saquib N, Wallace RB, Wild RA, Pfeiffer RM, Xu X, Trabert B (2021). Analgesic use and circulating estrogens, androgens, and their metabolites in the Women's Health Initiative Observational Study. Cancer Prev Res (Phila), 15, 173-183. (Read full article)
  48. Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, Harris HR, Matsuo K, Menon U, Modugno F, Moysich KB, Qin B, Ramus SJ, Risch HA, Rossing MA, Schildkraut JM, Trabert B, Vierkant RA, Winham SJ, Wentzensen N, Wu AH, Ziogas A, Khoja L, Cho KR, McLean K, Richardson J, Grout B, Chase A, McKinnon Deurloo C, Odunsi K, Nelson BH, Brenton JD, Terry KL, Pharaoh PD, Berchuck A, Hanley GE, Webb PM, Pike MC, Pearce CL (2021). High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival. Cancer Epidemiol Biomarkers Prev, 31, 443-452. (Read full article)
  49. Camargo MC, Song M, Xu X, Zhao I, Sampson JN, Etemadi A, Brenner H, Lee HW, Trabert B, Holleczek B, Schttker B, Spaid K, Dawsey SM, Lee S, Shimura T, Park SK, Malekzadeh R, Kang D, Rabkin CS (2021). Urinary estrogen metabolites and gastric cancer risk among postmenopausal women. Cancer Rep (Hoboken), 5, e1574. (Read full article)
  50. Trabert B, Hathaway CA, Rice MS, Rimm EB, Sluss PM, Terry KL, Zeleznik OA, Tworoger SS (2021). Ovarian Cancer Risk in Relation to Blood Cholesterol and Triglycerides. Cancer Epidemiol Biomarkers Prev, 30(11), 2044-2051. (Read full article)
  51. Oh H, Wild RA, Manson JE, Bea JW, Shadyab AH, Pfeiffer RM, Saquib N, Underland L, Anderson GL, Xu X, Trabert B (2021). Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev, 30(11), 2018-2029. (Read full article)
  52. Trabert B, Geczik AM, Bauer DC, Buist DSM, Cauley JA, Falk RT, Gierach GL, Hue TF, Lacey JV Jr, LaCroix AZ, Michels KA, Tice JA, Xu X, Brinton LA, Dallal CM (2021). Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B∼FIT Cohort. Cancer Epidemiol Biomarkers Prev, 30(11), 2030-2037. (Read full article)
  53. Oh H, Saquib N, Ochs-Balcom HM, Pfeiffer RM, Richey PA, Shadyab AH, Wild RA, Underland L, Anderson GL, Xu X, Trabert B (2021). Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev, 31, 97-107. (Read full article)
  54. Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, Giles GG, Irvin SR, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Koh WP, Lacey JV, Langseth H, Larsson SC, Lee IM, Martnez ME, Merritt MA, Milne RL, OBrien KM, Orlich MJ, Palmer JR, Patel AV, Peters U, Poynter JN, Robien K, Rohan TE, Rosenberg L, Sandin S, Sandler DP, Schouten LJ, Setiawan VW, Swerdlow AJ, Ursin G, van den Brandt PA, Visvanathan K, Weiderpass E, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Tworoger SS, Wentzensen N (2021). Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). Int J Epidemiol, 51, e73-e86. (Read full article)
  55. Sasamoto N, Babic A, Vitonis AF, Titus L, Cramer DW, Trabert B, Tworoger SS, Terry KL (2021). Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk. Cancer Prev Res (Phila), 14(8), 795-802. (Read full article)
  56. Saint-Maurice PF, Sampson JN, Michels KA, Moore SC, Loftfield E, McClain K, Cook MB, Trabert B, Matthews CE (2021). Physical Activity From Adolescence Through Midlife and Associations With Body Mass Index and Endometrial Cancer Risk. JNCI Cancer Spectr, 5(4), pkab065. (Read full article)
  57. Virani S, Baiocchi G, Bowtell D, Cabasag CJ, Cho KR, Fortner RT, Fujiwara K, Kim JW, Kbel M, Kurtz JE, Levine DA, Menon U, Norquist BM, Pharoah PDP, Sood AK, Tworoger ST, Wentzensen N, Chanock SJ, Brennan P, Trabert B (2021). Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research. Carcinogenesis, 42(6), 785-793. (Read full article)
  58. Hurwitz LM, Pinsky PF, Trabert B (2021). General population screening for ovarian cancer. Lancet, 397(10290), 2128-2130. (Read full article)
  59. OBrien KM, Tworoger SS, Harris HR, Trabert B, Weinberg CR, Fortner RT, DAloisio AA, Kaunitz AM, Wentzensen N, Sandler DP (2021). Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies. Int J Cancer, 148(11), 2692-2701. (Read full article)
  60. King LA, Michels KA, Graubard BI, Trabert B (2021). Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017. Cancer Causes Control, 32(6), 587-595. (Read full article)
  61. Michels KA, Geczik AM, Bauer DC, Brinton LA, Buist DSM, Cauley JA, Dallal CM, Falk RT, Hue TF, Lacey JV Jr, LaCroix AZ, Tice JA, Xu X, Trabert B (2021). Endogenous Progestogens and Colorectal Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev, 30(6), 1100-1105. (Read full article)
  62. Jordan SJ, Na R, Weiderpass E, Adami HO, Anderson KE, van den Brandt PA, Brinton LA, Chen C, Cook LS, Doherty JA, Du M, Friedenreich CM, Gierach GL, Goodman MT, Krogh V, Levi F, Lu L, Miller AB, McCann SE, Moysich KB, Negri E, Olson SH, Petruzella S, Palmer JR, Parazzini F, Pike MC, Prizment AE, Rebbeck TR, Reynolds P, Ricceri F, Risch HA, Rohan TE, Sacerdote C, Schouten LJ, Serraino D, Setiawan VW, Shu XO, Sponholtz TR, Spurdle AB, Stolzenberg-Solomon RZ, Trabert B, Wentzensen N, Wilkens LR, Wise LA, Yu H, La Vecchia C, De Vivo I, Xu W, Zeleniuch-Jacquotte A, Webb PM (2020). Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium. Int J Cancer, 148(9), 2068-2078. (Read full article)
  63. Baumeister SE, Schlecht I, Trabert B, Nolde M, Meisinger C, Leitzmann MF (2021). Anthropometric risk factors for ovarian cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control, 32(3), 231-239. (Read full article)
  64. Hurwitz LM, Michels KA, Cook MB, Pfeiffer RM, Trabert B (2020). Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts. Cancer Causes Control, 32(1), 57-65. (Read full article)
  65. Hurwitz LM, Pinsky PF, Huang WY, Freedman ND, Trabert B (2020). Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening Trial. Gynecol Oncol, 159(2), 522-526. (Read full article)
  66. Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, Leong HS, Chen S, Intermaggio MP, Gilks B, Nazeran TM, Volchek M, Elatre W, Bentley RC, Senz J, Lum A, Chow V, Sudderuddin H, Mackenzie R, Leong SCY, Liu G, Johnson D, Chen B, Group A, Alsop J, Banerjee SN, Behrens S, Bodelon C, Brand AH, Brinton L, Carney ME, Chiew YE, Cushing-Haugen KL, Cybulski C, Ennis D, Fereday S, Fortner RT, Garca-Donas J, Gentry-Maharaj A, Glasspool R, Goranova T, Greene CS, Haluska P, Harris HR, Hendley J, Hernandez BY, Herpel E, Jimenez-Linan M, Karpinskyj C, Kaufmann SH, Keeney GL, Kennedy CJ, Kbel M, Koziak JM, Larson MC, Lester J, Lewsley LA, Lissowska J, Lubiski J, Luk H, Macintyre G, Mahner S, McNeish IA, Menkiszak J, Nevins N, Osorio A, Oszurek O, Palacios J, Hinsley S, Pearce CL, Pike MC, Piskorz AM, Ray-Coquard I, Rhenius V, Rodriguez-Antona C, Sharma R, Sherman ME, De Silva D, Singh N, Sinn P, Slamon D, Song H, Steed H, Stronach EA, Thompson PJ, Tooczko A, Trabert B, Traficante N, Tseng CC, Widschwendter M, Wilkens LR, Winham SJ, Winterhoff B, Beeghly-Fadiel A, Benitez J, Berchuck A, Brenton JD, Brown R, Chang-Claude J, Chenevix-Trench G, deFazio A, Fasching PA, Garca MJ, Gayther SA, Goodman MT, Gronwald J, Henderson MJ, Karlan BY, Kelemen LE, Menon U, Orsulic S, Pharoah PDP, Wentzensen N, Wu AH, Schildkraut JM, Rossing MA, Konecny GE, Huntsman DG, Huang RY, Goode EL, Ramus SJ, Doherty JA, Bowtell DD, Anglesio MS (2020). Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). Clin Cancer Res, 26(20), 5411-5423. (Read full article)
  67. Irvin S, Clarke MA, Trabert B, Wentzensen N (2020). Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer. Cancer Causes Control, 31(10), 869-879. (Read full article)
  68. Fortner RT, Rice MS, Knutsen SF, Orlich MJ, Visvanathan K, Patel AV, Gaudet MM, Tjnneland A, Kvaskoff M, Kaaks R, Trichopolou A, Pala V, Onland-Moret NC, Gram IT, Amiano P, Idahl A, Allen NE, Weiderpass E, Poynter JN, Robien K, Giles GG, Milne RL, Setiawan VW, Merritt MA, van den Brandt PA, Zeleniuch-Jacquotte A, Arslan AA, OBrien KM, Sandler DP, Wolk A, Hkansson N, Harris HR, Trabert B, Wentzensen N, Tworoger SS, Schouten LJ (2020). Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev, 29(10), 2010-2018. (Read full article)
  69. Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, Chen S, Elatre W, Gilks B, Nazeran T, Volchek M, Bentley RC, Wang C, Chiu DS, Kommoss S, Leung SCY, Senz J, Lum A, Chow V, Sudderuddin H, Mackenzie R, George J, AOCS Group, Fereday S, Hendley J, Traficante N, Steed H, Koziak JM, Kbel M, McNeish IA, Goranova T, Ennis D, Macintyre G, Silva De Silva D, Ramn Y Cajal T, Garca-Donas J, Hernando Polo S, Rodriguez GC, Cushing-Haugen KL, Harris HR, Greene CS, Zelaya RA, Behrens S, Fortner RT, Sinn P, Herpel E, Lester J, Lubiski J, Oszurek O, Tooczko A, Cybulski C, Menkiszak J, Pearce CL, Pike MC, Tseng C, Alsop J, Rhenius V, Song H, Jimenez-Linan M, Piskorz AM, Gentry-Maharaj A, Karpinskyj C, Widschwendter M, Singh N, Kennedy CJ, Sharma R, Harnett PR, Gao B, Johnatty SE, Sayer R, Boros J, Winham SJ, Keeney GL, Kaufmann SH, Larson MC, Luk H, Hernandez BY, Thompson PJ, Wilkens LR, Carney ME, Trabert B, Lissowska J, Brinton L, Sherman ME, Bodelon C, Hinsley S, Lewsley LA, Glasspool R, Banerjee SN, Stronach EA, Haluska P, Ray-Coquard I, Mahner S, Winterhoff B, Slamon D, Levine DA, Kelemen LE, Benitez J, Chang-Claude J, Gronwald J, Wu AH, Menon U, Goodman MT, Schildkraut JM, Wentzensen N, Brown R, Berchuck A, Chenevix-Trench G, deFazio A, Gayther SA, Garca MJ, Henderson MJ, Rossing MA, Beeghly-Fadiel A, Fasching PA, Orsulic S, Karlan BY, Konecny GE, Huntsman DG, Bowtell DD, Brenton JD, Doherty JA, Pharoah PDP, Ramus SJ (2020). Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol, 31(9), 1240-1250. (Read full article)
  70. Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, Doherty JA, Fortner RT, Garsed DW, Gayther SA, Gentry-Maharaj A, Goode EL, Goodman MT, Harris HR, Hgdall E, Huntsman DG, Shen H, Jensen A, Johnatty SE, Jordan SJ, Kjaer SK, Kupryjanczyk J, Lambrechts D, McLean K, Menon U, Modugno F, Moysich K, Ness R, Ramus SJ, Richardson J, Risch H, Rossing MA, Trabert B, Wentzensen N, Ziogas A, Terry KL, Wu AH, Hanley GE, Pharoah P, Webb PM, Pike MC, Pearce CL, Ovarian Cancer Association Consortium (2020). Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. Gynecol Oncol, 158(3), 702-709. (Read full article)
  71. Skld C, Bjrge T, Ekbom A, Engeland A, Gissler M, Grotmol T, Madanat-Harjuoja L, Ording AG, Trabert B, Tretli S, Troisi R, Srensen HT, Glimelius I (2020). Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study. Br J Cancer, 123(1), 161-166. (Read full article)
  72. Trabert B, Sherman ME, Kannan N, Stanczyk FZ (2018). Progesterone and Breast Cancer. Endocr Rev, 41(2). (Read full article)
  73. Eldridge RC, Wentzensen N, Pfeiffer RM, Brinton LA, Hartge P, Guillemette C, Kemp TJ, Pinto LA, Trabert B (2020). Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease. Cancer Causes Control, 31(4), 309-320. (Read full article)
  74. Trabert B, Bauer DC, Buist DSM, Cauley JA, Falk RT, Geczik AM, Gierach GL, Hada M, Hue TF, Lacey JV Jr, LaCroix AZ, Tice JA, Xu X, Dallal CM, Brinton LA (2020). Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women. JAMA Netw Open, 3(4), e203645. (Read full article)
  75. Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, Glimelius I, Madanat-Harjuoja L, Srensen HT, Tretli S, Gulbech Ording A, Bjrge T (2019). Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. Int J Cancer, 146(6), 1523-1531. (Read full article)
  76. Matthews CE, Moore SC, Arem H, Cook MB, Trabert B, Hkansson N, Larsson SC, Wolk A, Gapstur SM, Lynch BM, Milne RL, Freedman ND, Huang WY, Berrington de Gonzalez A, Kitahara CM, Linet MS, Shiroma EJ, Sandin S, Patel AV, Lee IM (2019). Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk. J Clin Oncol, 38(7), 686-697. (Read full article)
  77. Irvin SR, Weiderpass E, Stanczyk FZ, Brinton LA, Trabert B, Langseth H, Wentzensen N (2020). Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank. Cancer Epidemiol Biomarkers Prev, 29(3), 636-642. (Read full article)
  78. Trabert B, Tworoger SS, OBrien KM, Townsend MK, Fortner RT, Iversen ES, Hartge P, White E, Amiano P, Arslan AA, Bernstein L, Brinton LA, Buring JE, Dossus L, Fraser GE, Gaudet MM, Giles GG, Gram IT, Harris HR, Bolton JH, Idahl A, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Kvaskoff M, Lacey JV, Lee IM, Milne RL, Onland-Moret NC, Overvad K, Patel AV, Peters U, Poynter JN, Riboli E, Robien K, Rohan TE, Sandler DP, Schairer C, Schouten LJ, Setiawan VW, Swerdlow AJ, Travis RC, Trichopoulou A, van den Brandt PA, Visvanathan K, Wilkens LR, Wolk A, Zeleniuch-Jacquotte A, Wentzensen N, Ovarian Cancer Cohort Consortium OC3 (2020). The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3). Cancer Res, 80(5), 1210-1218. (Read full article)
  79. Aarestrup J, Jensen BW, Ulrich LG, Hartwell D, Trabert B, Baker JL (2020). Birth weight, childhood body mass index and height and risks of endometriosis and adenomyosis. Ann Hum Biol, 47(2), 173-180. (Read full article)
  80. Howland RE, Deziel NC, Bentley GR, Booth M, Choudhury OA, Hofmann JN, Hoover RN, Katki HA, Trabert B, Fox SD, Troisi R, Houghton LC (2020). Assessing Endogenous and Exogenous Hormone Exposures and Breast Development in a Migrant Study of Bangladeshi and British Girls. Int J Environ Res Public Health, 17(4). (Read full article)
  81. Cabasag CJ, Arnold M, Butler J, Inoue M, Trabert B, Webb PM, Bray F, Soerjomataram I (2019). The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer, 146(3), 749-758. (Read full article)
  82. Hada M, Oh H, Fan S, Falk RT, Geller B, Vacek P, Weaver D, Shepherd J, Wang J, Fan B, Herschorn S, Brinton LA, Xu X, Sherman ME, Trabert B, Gierach GL (2020). Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy. J Clin Med, 9(1). (Read full article)
  83. OBrien KM, Tworoger SS, Harris HR, Anderson GL, Weinberg CR, Trabert B, Kaunitz AM, DAloisio AA, Sandler DP, Wentzensen N (2020). Association of Powder Use in the Genital Area With Risk of Ovarian Cancer. JAMA, 323(1), 49-59. (Read full article)
  84. Huang T, Townsend MK, Wentzensen N, Trabert B, White E, Arslan AA, Weiderpass E, Buring JE, Clendenen TV, Giles GG, Lee IM, Milne RL, Onland-Moret NC, Peters U, Sandler DP, Schouten LJ, van den Brandt PA, Wolk A, Zeleniuch-Jacquotte A, Tworoger SS (2019). Reproductive and Hormonal Factors and Risk of Ovarian Cancer by Tumor Dominance: Results from the Ovarian Cancer Cohort Consortium (OC3). Cancer Epidemiol Biomarkers Prev, 29(1), 200-207. (Read full article)
  85. Sasamoto N, Babic A, Rosner BA, Fortner RT, Vitonis AF, Yamamoto H, Fichorova RN, Titus LJ, Tjnneland A, Hansen L, Kvaskoff M, Fournier A, Mancini FR, Boeing H, Trichopoulou A, Peppa E, Karakatsani A, Palli D, Grioni S, Mattiello A, Tumino R, Fiano V, Onland-Moret NC, Weiderpass E, Gram IT, Quirs JR, Lujan-Barroso L, Snchez MJ, Colorado-Yohar S, Barricarte A, Amiano P, Idahl A, Lundin E, Sartor H, Khaw KT, Key TJ, Muller D, Riboli E, Gunter M, Dossus L, Trabert B, Wentzensen N, Kaaks R, Cramer DW, Tworoger SS, Terry KL (2019). Development and validation of circulating CA125 prediction models in postmenopausal women. J Ovarian Res, 12(1), 116. (Read full article)
  86. Michels KA, McNeel TS, Trabert B (2019). Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data. Gynecol Oncol, 155(2), 294-300. (Read full article)
  87. Trabert B, Coburn SB, Falk RT, Manson JE, Brinton LA, Gass ML, Kuller LH, Rohan TE, Pfeiffer RM, Qi L, Stefanick ML, Wentzensen N, Anderson GL, Xu X (2019). Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study. Cancer Causes Control, 30(11), 1201-1211. (Read full article)
  88. Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X (2019). Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Int J Cancer, 145(8), 2051-2060. (Read full article)
  89. Peres LC, Mallen AR, Townsend MK, Poole EM, Trabert B, Allen NE, Arslan AA, Dossus L, Fortner RT, Gram IT, Hartge P, Idahl A, Kaaks R, Kvaskoff M, Magliocco AM, Merritt MA, Quirs JR, Tjonneland A, Trichopoulou A, Tumino R, van Gils CH, Visvanathan K, Wentzensen N, Zeleniuch-Jacquotte A, Tworoger SS (2019). High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium. Cancer Res, 79(20), 5442-5451. (Read full article)
  90. Michels KA, Brinton LA, Wentzensen N, Pan K, Chen C, Anderson GL, Pfeiffer RM, Xu X, Rohan TE, Trabert B (2019). Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study. JNCI Cancer Spectr, 3(3), pkz029. (Read full article)
  91. Huang WY, Berndt SI, Shiels MS, Katki HA, Chaturvedi AK, Wentzensen N, Trabert B, Kemp TJ, Pinto LA, Hildesheim A, Rothman N, Purdue MP (2018). Circulating inflammation markers and colorectal adenoma risk. Carcinogenesis, 40(6), 765-770. (Read full article)
  92. Fortner RT, Poole EM, Wentzensen NA, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Clendenen TV, Fournier A, Fraser G, Gapstur SM, Gaudet MM, Giles GG, Gram IT, Hartge P, Hoffman-Bolton J, Idahl A, Kaaks R, Kirsh VA, Knutsen S, Koh WP, Lacey JV Jr, Lee IM, Lundin E, Merritt MA, Milne RL, Onland-Moret NC, Peters U, Poynter JN, Rinaldi S, Robien K, Rohan T, Snchez MJ, Schairer C, Schouten LJ, Tjonneland A, Townsend MK, Travis RC, Trichopoulou A, van den Brandt PA, Vineis P, Wilkens L, Wolk A, Yang HP, Zeleniuch-Jacquotte A, Tworoger SS (2019). Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium. Int J Cancer, 145(1), 58-69. (Read full article)
  93. Stang A, Rusner C, Trabert B, Oosterhuis JW, McGlynn KA, Heidinger O (2018). Incidence of testicular tumor subtypes according to the updated WHO classification, North Rhine-Westphalia, Germany, 2008-2013. Andrology, 7(4), 402-407. (Read full article)
  94. Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Salvatore M, Tworoger SS, Whittemore AS, Anton-Culver H, Sieh W, Olson SH, Berchuck A, Goode EL, Goodman MT, Doherty JA, Chenevix-Trench G, Rossing MA, Webb PM, Giles GG, Terry KL, Ziogas A, Fortner RT, Menon U, Gayther SA, Wu AH, Song H, Brooks-Wilson A, Bandera EV, Cook LS, Cramer DW, Milne RL, Winham SJ, Kjaer SK, Modugno F, Thompson PJ, Chang-Claude J, Harris HR, Schildkraut JM, Le ND, Wentzensen N, Trabert B, Hgdall E, Huntsman D, Pike MC, Pharoah PDP, Pearce CL, Mukherjee B (2019). A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants. Int J Cancer, 144(9), 2192-2205. (Read full article)
  95. Lu J, Trabert B, Liao LM, Pfeiffer RM, Michels KA (2018). Dietary intake of nutrients involved in folate-mediated one-carbon metabolism and risk for endometrial cancer. Int J Epidemiol, 48(2), 474-488. (Read full article)
  96. Cantonwine DE, McElrath TF, Trabert B, Xu X, Sampson J, Roberts JM, Hoover RN, Troisi R (2019). Estrogen metabolism pathways in preeclampsia and normal pregnancy. Steroids, 144, 8-14. (Read full article)
  97. Falk RT, Manson JE, Barnabei VM, Anderson GL, Brinton LA, Rohan TE, Cauley JA, Chen C, Coburn SB, Pfeiffer RM, Reding KW, Sarto GE, Wentzensen N, Chlebowski RT, Xu X, Trabert B (2018). Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone? Int J Cancer, 144(4), 730-740. (Read full article)
  98. Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N (2018). Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations. J Natl Cancer Inst, 111(2), 129-136. (Read full article)
  99. Trabert B, Poole EM, White E, Visvanathan K, Adami HO, Anderson GL, Brasky TM, Brinton LA, Fortner RT, Gaudet M, Hartge P, Hoffman-Bolton J, Jones M, Lacey JV, Larsson SC, Mackenzie GG, Schouten LJ, Sandler DP, OBrien K, Patel AV, Peters U, Prizment A, Robien K, Setiawan VW, Swerdlow A, van den Brandt PA, Weiderpass E, Wilkens LR, Wolk A, Wentzensen N, Tworoger SS, Ovarian Cancer Cohort Consortium OC3 (2018). Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. J Natl Cancer Inst, 111(2), 137-145. (Read full article)
  100. Webb PM, Na R, Weiderpass E, Adami HO, Anderson KE, Bertrand KA, Botteri E, Brasky TM, Brinton LA, Chen C, Doherty JA, Lu L, McCann SE, Moysich KB, Olson S, Petruzella S, Palmer JR, Prizment AE, Schairer C, Setiawan VW, Spurdle AB, Trabert B, Wentzensen N, Wilkens L, Yang HP, Yu H, Risch HA, Jordan SJ (2018). Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium. Ann Oncol, 30(2), 310-316. (Read full article)
  101. Hada M, Edin ML, Hartge P, Lih FB, Wentzensen N, Zeldin DC, Trabert B (2018). Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev, 28(1), 189-197. (Read full article)
  102. Aarestrup J, Trabert B, Ulrich LG, Wentzensen N, Srensen TIA, Baker JL (2018). Childhood Overweight, Tallness, and Growth Increase Risks of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev, 28(1), 183-188. (Read full article)
  103. Coburn SB, Stanczyk FZ, Falk RT, McGlynn KA, Brinton LA, Sampson J, Bradwin G, Xu X, Trabert B (2018). Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status. Cancer Causes Control, 30(1), 75-86. (Read full article)
  104. Samimi G, Trabert B, Geczik AM, Duggan MA, Sherman ME (2018). Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol. JNCI Cancer Spectr, 2(4), pky061. (Read full article)
  105. Skld C, Bjrge T, Ekbom A, Engeland A, Gissler M, Grotmol T, Madanat-Harjuoja L, Gulbech Ording A, Stephansson O, Trabert B, Tretli S, Troisi R, Srensen HT, Glimelius I (2018). Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. Int J Cancer, 143(8), 1858-1867. (Read full article)
  106. Troisi R, Gulbech Ording A, Grotmol T, Glimelius I, Engeland A, Gissler M, Trabert B, Ekbom A, Madanat-Harjuoja L, Srensen HT, Tretli S, Bjrge T (2018). Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. Int J Cancer, 143(8), 1904-1913. (Read full article)
  107. Michels KA, Brinton LA, Pfeiffer RM, Trabert B (2017). Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol, 187(8), 1630-1641. (Read full article)
  108. Ghazarian AA, Rusner C, Trabert B, Braunlin M, McGlynn KA, Stang A (2018). Testicular cancer among US men aged 50 years and older. Cancer Epidemiol, 55, 68-72. (Read full article)
  109. Trabert B, Coburn SB, Mariani A, Yang HP, Rosenberg PS, Gierach GL, Wentzensen N, Cronin KA, Sherman ME (2017). Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries. J Natl Cancer Inst, 110(7), 750-757. (Read full article)
  110. Ghazarian AA, Trabert B, Robien K, Graubard BI, McGlynn KA (2018). Maternal use of personal care products during pregnancy and risk of testicular germ cell tumors in sons. Environ Res, 164, 109-113. (Read full article)
  111. Ghazarian AA, Trabert B, Graubard BI, Longnecker MP, Klebanoff MA, McGlynn KA (2017). Placental Weight and Risk of Cryptorchidism and Hypospadias in the Collaborative Perinatal Project. Am J Epidemiol, 187(7), 1354-1361. (Read full article)
  112. Coburn SB, Graubard BI, Trabert B, McGlynn KA, Cook MB (2018). Associations between circulating sex steroid hormones and leukocyte telomere length in men in the National Health and Nutrition Examination Survey. Andrology, 6(4), 542-546. (Read full article)
  113. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL (2018). Ovarian cancer statistics, 2018. CA Cancer J Clin, 68(4), 284-296. (Read full article)
  114. Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews CE, Ziegler RG (2017). A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst, 110(6), 588-597. (Read full article)
  115. Troisi R, Bjrge T, Gissler M, Grotmol T, Kitahara CM, Myrtveit Saether SM, Ording AG, Skld C, Srensen HT, Trabert B, Glimelius I (2018). The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med, 283(5), 430-445. (Read full article)
  116. Ong JS, Hwang LD, Cuellar-Partida G, Martin NG, Chenevix-Trench G, Quinn MCJ, Cornelis MC, Gharahkhani P, Webb PM, MacGregor S, Ovarian Cancer Association Consortium including Trabert B (2017). Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol, 47(2), 450-459. (Read full article)
  117. Michels KA, Pfeiffer RM, Brinton LA, Trabert B (2018). Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers. JAMA Oncol, 4(4), 516-521. (Read full article)
  118. Trabert B, Aarestrup J, Ulrich LG, Wentzensen N, Srensen TIA, Baker JL (2018). Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register. Gynecol Oncol, 148(3), 547-552. (Read full article)
  119. Samimi G, Trabert B, Duggan MA, Robinson JL, Coa KI, Waibel E, Garcia E, Minasian LM, Sherman ME (2017). Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices. Gynecol Oncol, 148(3), 515-520. (Read full article)
  120. Playdon MC, Coburn SB, Moore SC, Brinton LA, Wentzensen N, Anderson G, Wallace R, Falk RT, Pfeiffer R, Xu X, Trabert B (2017). Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational Study. Br J Cancer, 118(3), 448-457. (Read full article)
  121. Oh H, Arem H, Matthews CE, Wentzensen N, Reding KW, Brinton LA, Anderson GL, Coburn SB, Cauley JA, Chen C, Goodman D, Pfeiffer RM, Falk RT, Xu X, Trabert B (2017). Sitting, physical activity, and serum oestrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Br J Cancer, 117(7), 1070-1078. (Read full article)
  122. Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M (2017). Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States. PLoS One, 12(7), e0182359. (Read full article)
  123. Ose J, Poole EM, Schock H, Lehtinen M, Arslan AA, Zeleniuch-Jacquotte A, Visvanathan K, Helzlsouer K, Buring JE, Lee IM, Tjnneland A, Dossus L, Trichopoulou A, Masala G, Onland-Moret NC, Weiderpass E, Duell EJ, Idahl A, Travis RC, Rinaldi S, Merritt MA, Trabert B, Wentzensen N, Tworoger SS, Kaaks R, Fortner RT (2017). Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium. Cancer Res, 77(14), 3951-3960. (Read full article)
  124. Thistle JE, Graubard BI, Braunlin M, Vesper H, Trabert B, Cook MB, McGlynn KA (2017). Marijuana use and serum testosterone concentrations among U.S. males. Andrology, 5(4), 732-738. (Read full article)
  125. Coburn SB, Bray F, Sherman ME, Trabert B (2017). International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer, 140(11), 2451-2460. (Read full article)
  126. Brinton LA, Thistle JE, Liao LM, Trabert B (2017). Epidemiology of vulvar neoplasia in the NIH-AARP Study. Gynecol Oncol, 145(2), 298-304. (Read full article)
  127. Cannioto RA, Trabert B, Poole EM, Schildkraut JM (2017). Ovarian cancer epidemiology in the era of collaborative team science. Cancer Causes Control, 28(5), 487-495. (Read full article)
  128. Zhou Z, Zeng F, Yuan J, Tang J, Colditz GA, Tworoger SS, Trabert B, Su X (2017). Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis. Cancer Causes Control, 28(5), 415-428. (Read full article)
  129. Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, Earp MA, Lyra PC Jr, Lee JM, Coetzee S, Beesley J, McGuffog L, Soucy P, Dicks E, Lee A, Barrowdale D, Lecarpentier J, Leslie G, Aalfs CM, Aben KKH, Adams M, Adlard J, Andrulis IL, Anton-Culver H, Antonenkova N, AOCS study group, Aravantinos G, Arnold N, Arun BK, Arver B, Azzollini J, Balmaa J, Banerjee SN, Barjhoux L, Barkardottir RB, Bean Y, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bermisheva M, Bernardini MQ, Birrer MJ, Bjorge L, Black A, Blankstein K, Blok MJ, Bodelon C, Bogdanova N, Bojesen A, Bonanni B, Borg, Bradbury AR, Brenton JD, Brewer C, Brinton L, Broberg P, Brooks-Wilson A, Bruinsma F, Brunet J, Buecher B, Butzow R, Buys SS, Caldes T, Caligo MA, Campbell I, Cannioto R, Carney ME, Cescon T, Chan SB, Chang-Claude J, Chanock S, Chen XQ, Chiew YE, Chiquette J, Chung WK, Claes KBM, Conner T, Cook LS, Cook J, Cramer DW, Cunningham JM, DAloisio AA, Daly MB, Damiola F, Damirovna SD, Dansonka-Mieszkowska A, Dao F, Davidson R, DeFazio A, Delnatte C, Doheny KF, Diez O, Ding YC, Doherty JA, Domchek SM, Dorfling CM, Drk T, Dossus L, Duran M, Drst M, Dworniczak B, Eccles D, Edwards T, Eeles R, Eilber U, Ejlertsen B, Ekici AB, Ellis S, Elvira M, EMBRACE Study, Eng KH, Engel C, Evans DG, Fasching PA, Ferguson S, Ferrer SF, Flanagan JM, Fogarty ZC, Fortner RT, Fostira F, Foulkes WD, Fountzilas G, Fridley BL, Friebel TM, Friedman E, Frost D, Ganz PA, Garber J, Garca MJ, Garcia-Barberan V, Gehrig A, GEMO Study Collaborators, Gentry-Maharaj A, Gerdes AM, Giles GG, Glasspool R, Glendon G, Godwin AK, Goldgar DE, Goranova T, Gore M, Greene MH, Gronwald J, Gruber S, Hahnen E, Haiman CA, Hkansson N, Hamann U, Hansen TVO, Harrington PA, Harris HR, Hauke J, HEBON Study, Hein A, Henderson A, Hildebrandt MAT, Hillemanns P, Hodgson S, Hgdall CK, Hgdall E, Hogervorst FBL, Holland H, Hooning MJ, Hosking K, Huang RY, Hulick PJ, Hung J, Hunter DJ, Huntsman DG, Huzarski T, Imyanitov EN, Isaacs C, Iversen ES, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jernetz M, Jensen A, Jensen UB, John EM, Johnatty S, Jones ME, Kannisto P, Karlan BY, Karnezis A, Kast K, KConFab Investigators, Kennedy CJ, Khusnutdinova E, Kiemeney LA, Kiiski JI, Kim SW, Kjaer SK, Kbel M, Kopperud RK, Kruse TA, Kupryjanczyk J, Kwong A, Laitman Y, Lambrechts D, Larraaga N, Larson MC, Lazaro C, Le ND, Le Marchand L, Lee JW, Lele SB, Leminen A, Leroux D, Lester J, Lesueur F, Levine DA, Liang D, Liebrich C, Lilyquist J, Lipworth L, Lissowska J, Lu KH, Lubinski J, Luccarini C, Lundvall L, Mai PL, Mendoza-Fandio G, Manoukian S, Massuger LFAG, May T, Mazoyer S, McAlpine JN, McGuire V, McLaughlin JR, McNeish I, Meijers-Heijboer H, Meindl A, Menon U, Mensenkamp AR, Merritt MA, Milne RL, Mitchell G, Modugno F, Moes-Sosnowska J, Moffitt M, Montagna M, Moysich KB, Mulligan AM, Musinsky J, Nathanson KL, Nedergaard L, Ness RB, Neuhausen SL, Nevanlinna H, Niederacher D, Nussbaum RL, Odunsi K, Olah E, Olopade OI, Olsson H, Olswold C, OMalley DM, Ong KR, Onland-Moret NC, OPAL study group, Orr N, Orsulic S, Osorio A, Palli D, Papi L, Park-Simon TW, Paul J, Pearce CL, Pedersen IS, Peeters PHM, Peissel B, Peixoto A, Pejovic T, Pelttari LM, Permuth JB, Peterlongo P, Pezzani L, Pfeiler G, Phillips KA, Piedmonte M, Pike MC, Piskorz AM, Poblete SR, Pocza T, Poole EM, Poppe B, Porteous ME, Prieur F, Prokofyeva D, Pugh E, Pujana MA, Pujol P, Radice P, Rantala J, Rappaport-Fuerhauser C, Rennert G, Rhiem K, Rice P, Richardson A, Robson M, Rodriguez GC, Rodrguez-Antona C, Romm J, Rookus MA, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Salvesen HB, Sandler DP, Schoemaker MJ, Senter L, Setiawan VW, Severi G, Sharma P, Shelford T, Siddiqui N, Side LE, Sieh W, Singer CF, Sobol H, Song H, Southey MC, Spurdle AB, Stadler Z, Steinemann D, Stoppa-Lyonnet D, Sucheston-Campbell LE, Sukiennicki G, Sutphen R, Sutter C, Swerdlow AJ, Szabo CI, Szafron L, T (2017). Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet, 49(5), 680-691. (Read full article)
  130. Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Australian Ovarian Cancer Study Group, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Ness RB, Edwards RP, Jensen A, Kjr SK, Hgdall E, Berchuck A, Cramer DW, Terry KL, Poole EM, Bandera EV, Paddock LE, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Webb PM (2017). Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Br J Cancer, 116(9), 1223-1228. (Read full article)
  131. Oh H, Coburn SB, Matthews CE, Falk RT, LeBlanc ES, Wactawski-Wende J, Sampson J, Pfeiffer RM, Brinton LA, Wentzensen N, Anderson GL, Manson JE, Chen C, Zaslavsky O, Xu X, Trabert B (2017). Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Breast Cancer Res, 19(1), 28. (Read full article)
  132. Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N (2016). Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Int J Cancer, 140(3), 600-610. (Read full article)
  133. Biggs ML, Doody DR, Trabert B, Starr JR, Chen C, Schwartz SM (2016). Consumption of alcoholic beverages in adolescence and adulthood and risk of testicular germ cell tumor. Int J Cancer, 139(11), 2405-14. (Read full article)
  134. Killian JK, Dorssers LC, Trabert B, Gillis AJ, Cook MB, Wang Y, Waterfall JJ, Stevenson H, Smith WI Jr, Noyes N, Retnakumar P, Stoop JH, Oosterhuis JW, Meltzer PS, McGlynn KA, Looijenga LH (2016). Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res, 26(11), 1490-1504. (Read full article)
  135. Ong JS, Cuellar-Partida G, Lu Y, Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Drk T, Drst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Hgdall E, Hgdall CK, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Stampfer M, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Gilks CB, Gronwald J, Jakubowska A, Lubiski J, Kluz T, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Campbell I, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poole EM, Morgan TK, Risch HA, Goode EL, Schildkraut JM, Pearce CL, Berchuck A, Pharoah PD, Chenevix-Trench G, Gharahkhani P, Neale RE, Webb PM, MacGregor S (2016). Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. Int J Epidemiol, 45(5), 1619-1630. (Read full article)
  136. Trabert B (2016). Body Powder and Ovarian Cancer Risk-What Is the Role of Recall Bias? Cancer Epidemiol Biomarkers Prev, 25(10), 1369-1370. (Read full article)
  137. Sherman ME, Drapkin RI, Horowitz NS, Crum CP, Friedman S, Kwon JS, Levine DA, Shih IeM, Shoupe D, Swisher EM, Walker J, Trabert B, Greene MH, Samimi G, Temkin SM, Minasian LM (2016). Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence. Cancer Prev Res (Phila), 9(9), 713-20. (Read full article)
  138. Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Butler LM, Chamosa S, Clendenen TV, Dossus L, Fortner R, Gapstur SM, Gaudet MM, Gram IT, Hartge P, Hoffman-Bolton J, Idahl A, Jones M, Kaaks R, Kirsh V, Koh WP, Lacey JV Jr, Lee IM, Lundin E, Merritt MA, Onland-Moret NC, Peters U, Poynter JN, Rinaldi S, Robien K, Rohan T, Sandler DP, Schairer C, Schouten LJ, Sjholm LK, Sieri S, Swerdlow A, Tjonneland A, Travis R, Trichopoulou A, van den Brandt PA, Wilkens L, Wolk A, Yang HP, Zeleniuch-Jacquotte A, Tworoger SS (2016). Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol, 34(24), 2888-98. (Read full article)
  139. Cuellar-Partida G, Lu Y, Dixon SC, Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Drk T, Drst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Hgdall E, Hgdall C, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Stampfer M, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Blake Gilks C, Gronwald J, Jakubowska A, Lubiski J, Kluz T, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Campbell I, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poole EM, Morgan TK, Goode EL, Schildkraut JM, Pearce CL, Berchuck A, Pharoah PD, Webb PM, Chenevix-Trench G, Risch HA, MacGregor S (2016). Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet, 135(7), 741-56. (Read full article)
  140. Brinton LA, Trabert B, Anderson GL, Falk RT, Felix AS, Fuhrman BJ, Gass ML, Kuller LH, Pfeiffer RM, Rohan TE, Strickler HD, Xu X, Wentzensen N (2016). Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev, 25(7), 1081-9. (Read full article)
  141. Stang A, Kowall B, Rusner C, Trabert B, Bray F, Schz J, McGlynn KA, Kuss O (2015). A novel method for identifying settings for well-motivated ecologic studies of cancer. Int J Cancer, 138(8), 1887-93. (Read full article)
  142. Trabert B, Brinton LA, Anderson GL, Pfeiffer RM, Falk RT, Strickler HD, Sliesoraitis S, Kuller LH, Gass ML, Fuhrman BJ, Xu X, Wentzensen N (2016). Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev, 25(4), 648-56. (Read full article)
  143. Lee AW, Templeman C, Stram DA, Beesley J, Tyrer J, Berchuck A, Pharoah PP, Chenevix-Trench G, Pearce CL, Ovarian Cancer Association Consortium including Trabert B (2015). Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril, 105(1), 35-43.e1-10. (Read full article)
  144. Trabert B, Xu X, Falk RT, Guillemette C, Stanczyk FZ, McGlynn KA (2015). Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol, 155(Pt A), 56-62. (Read full article)
  145. Ghazarian AA, Trabert B, Graubard BI, Schwartz SM, Altekruse SF, McGlynn KA (2015). Incidence of testicular germ cell tumors among US men by census region. Cancer, 121(23), 4181-9. (Read full article)
  146. Lu Y, Cuellar-Partida G, Painter JN, Nyholt DR, Australian Ovarian Cancer Study, International Endogene Consortium IEC, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Wicklund KG, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Drk T, Drst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Hgdall E, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Gilks CB, Gronwald J, Jakubowska A, Lubiski J, Gaweko J, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, Mclaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poole EM, Morgan TK, Risch HA, Goode EL, Schildkraut JM, Webb PM, Pearce CL, Berchuck A, Pharoah PD, Montgomery GW, Zondervan KT, Chenevix-Trench G, MacGregor S (2015). Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet, 24(20), 5955-64. (Read full article)
  147. Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff CL (2015). Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril, 104(4), 980-988. (Read full article)
  148. Trabert B, Falk RT, Stanczyk FZ, McGlynn KA, Brinton LA, Xu X (2015). Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry. Horm Mol Biol Clin Investig, 23(3), 79-84. (Read full article)
  149. Felix AS, Arem H, Trabert B, Gierach GL, Park Y, Pfeiffer RM, Brinton LA (2015). Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study. Cancer Causes Control, 26(8), 1055-63. (Read full article)
  150. Loftfield E, Shiels MS, Graubard BI, Katki HA, Chaturvedi AK, Trabert B, Pinto LA, Kemp TJ, Shebl FM, Mayne ST, Wentzensen N, Purdue MP, Hildesheim A, Sinha R, Freedman ND (2015). Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers. Cancer Epidemiol Biomarkers Prev, 24(7), 1052-60. (Read full article)
  151. Wentzensen N, Trabert B (2015). Hormone therapy: short-term relief, long-term consequences. Lancet, 385(9980), 1806-8. (Read full article)
  152. Felix AS, Bunch K, Yang HP, Arem H, Trabert B, Gierach GL, Park Y, Lowery WJ, Brinton LA (2015). Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study. Gynecol Oncol Rep, 13, 13-7. (Read full article)
  153. Trabert B, Chen Z, Kannan K, Peterson CM, Pollack AZ, Sun L, Buck Louis GM (2014). Persistent organic pollutants (POPs) and fibroids: results from the ENDO study. J Expo Sci Environ Epidemiol, 25(3), 278-85. (Read full article)
  154. Lang Kuhs KA, Hildesheim A, Trabert B, Kemp TJ, Purdue MP, Wentzensen N, Katki HA, Pinto LA, Loftfield E, Safaeian M, Chaturvedi AK, Shiels MS (2015). Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev, 24(5), 825-32. (Read full article)
  155. Yang HP, Cook LS, Weiderpass E, Adami HO, Anderson KE, Cai H, Cerhan JR, Clendenen TV, Felix AS, Friedenreich CM, Garcia-Closas M, Goodman MT, Liang X, Lissowska J, Lu L, Magliocco AM, McCann SE, Moysich KB, Olson SH, Petruzella S, Pike MC, Polidoro S, Ricceri F, Risch HA, Sacerdote C, Setiawan VW, Shu XO, Spurdle AB, Trabert B, Webb PM, Wentzensen N, Xiang YB, Xu Y, Yu H, Zeleniuch-Jacquotte A, Brinton LA (2015). Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). Br J Cancer, 112(5), 925-33. (Read full article)
  156. Pollack AZ, Buck Louis GM, Chen Z, Sun L, Trabert B, Guo Y, Kannan K (2014). Bisphenol A, benzophenone-type ultraviolet filters, and phthalates in relation to uterine leiomyoma. Environ Res, 137, 101-7. (Read full article)
  157. Trabert B, Wentzensen N, Felix AS, Yang HP, Sherman ME, Brinton LA (2015). Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Note: Recognized as one of 20 most frequently cited CEBP articles of 2015. Cancer Epidemiol Biomarkers Prev, 24(1), 261-7.
  158. Stang A, Trabert B, Rusner C, Poole C, Almstrup K, Rajpert-De Meyts E, McGlynn KA (2015). A survey of etiologic hypotheses among testicular cancer researchers. Andrology, 3(1), 19-26.
  159. Ghazarian AA, Trabert B, Devesa SS, McGlynn KA (2014). Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology, 3(1), 13-8. (Read full article)
  160. Trabert B, Chen J, Devesa SS, Bray F, McGlynn KA (2014). International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007. Andrology, 3(1), 4-12. (Read full article)
  161. Trabert B, Falk RT, Figueroa JD, Graubard BI, Garcia-Closas M, Lissowska J, Peplonska B, Fox SD, Brinton LA (2014). Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland. Cancer Causes Control, 25(12), 1587-93. (Read full article)
  162. Kitahara CM, Trabert B, Katki HA, Chaturvedi AK, Kemp TJ, Pinto LA, Moore SC, Purdue MP, Wentzensen N, Hildesheim A, Shiels MS (2014). Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance. Cancer Epidemiol Biomarkers Prev, 23(12), 2840-9. (Read full article)
  163. Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N (2014). Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol, 135(2), 297-304. (Read full article)
  164. Clark NM, Janz NK, Dodge JA, Lin X, Trabert BL, Kaciroti N, Mosca L, Wheeler JR, Keteyian S (2014). Heart disease management by women: does intervention format matter? Health Educ Behav, 41(5), 518-27. (Read full article)
  165. Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, Chang CM, Engels EA, Caporaso NE, Pinto LA, Hildesheim A, Chaturvedi AK (2014). Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst, 106(11). (Read full article)
  166. Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Ruggieri D, Trabert B, Lamb EJ (2014). Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiol Biomarkers Prev, 23(4), 584-93. (Read full article)
  167. Rusner C, Streller B, Stegmaier C, Trocchi P, Kuss O, McGlynn KA, Trabert B, Stang A (2014). Risk of second primary cancers after testicular cancer in East and West Germany: a focus on contralateral testicular cancers. Asian J Androl, 16(2), 285-9. (Read full article)
  168. Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, Severi G, Trabert B, Wentzensen N, Chenevix-Trench G, for AOCSACS group, Whittemore AS, Sieh W, Chang-Claude J, Bandera EV, Orlow I, Terry K, Goodman MT, Thompson PJ, Cook LS, Rossing MA, Ness RB, Narod SA, Kupryjanczyk J, Lu K, Butzow R, Drk T, Pejovic T, Campbell I, Le ND, Bunker CH, Bogdanova N, Runnebaum IB, Eccles D, Paul J, Wu AH, Gayther SA, Hogdall E, Heitz F, Kaye SB, Karlan BY, Anton-Culver H, Gronwald J, Hogdall CK, Lambrechts D, Fasching PA, Menon U, Schildkraut J, Pearce CL, Levine DA, Kjaer SK, Cramer D, Flanagan JM, Phelan CM, Brown R, Massuger LF, Song H, Doherty JA, Krakstad C, Liang D, Odunsi K, Berchuck A, Jensen A, Lubinski J, Nevanlinna H, Bean YT, Lurie G, Ziogas A, Walsh C, Despierre E, Brinton L, Hein A, Rudolph A, Dansonka-Mieszkowska A, Olson SH, Harter P, Tyrer J, Vitonis AF, Brooks-Wilson A, Aben KK, Pike MC, Ramus SJ, Wik E, Cybulski C, Lin J, Sucheston L, Edwards R, McGuire V, Lester J, du Bois A, Lundvall L, Wang-Gohrke S, Szafron LM, Lambrechts S, Yang H, Beckmann MW, Pelttari LM, Van Altena AM, van den Berg D, Halle MK, Gentry-Maharaj A, Schwaab I, Chandran U, Menkiszak J, Ekici AB, Wilkens LR, Leminen A, Modugno F, Friel G, Rothstein JH, Vergote I, Garcia-Closas M, Hildebrandt MA, Sobiczewski P, Kelemen LE, Pharoah PD, Moysich K, Knutson KL, Cunningham JM, Fridley BL, Goode EL (2013). Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res, 74(3), 852-61. (Read full article)
  169. Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, Australian Ovarian Cancer Study Group Australian Cancer Study Ovarian Cancer, Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjr SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N, Ovarian Cancer Association Consortium (2014). Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst, 106(2), djt431. (Read full article)
  170. Bonomi AE, Trabert B, Anderson ML, Kernic MA, Holt VL (2014). Intimate partner violence and neighborhood income: a longitudinal analysis. Violence Against Women, 20(1), 42-58. (Read full article)
  171. Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Brinton LA (2013). Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort. Fertil Steril, 100(6), 1660-6. (Read full article)
  172. Trabert B, Zugna D, Richiardi L, McGlynn KA, Akre O (2013). Congenital malformations and testicular germ cell tumors. Int J Cancer, 133(8), 1900-4. (Read full article)
  173. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, Moghissi KS (2013). Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod, 28(10), 2813-21. (Read full article)
  174. Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B (2013). Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol, 37(4), 374-7. (Read full article)
  175. Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, GEKID Cancer Survival Working Group (2013). Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. Cancer Epidemiol, 37(4), 492-7. (Read full article)
  176. Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A, Network of German Cancer Registries GEKID (2013). Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol, 37(4), 370-3. (Read full article)
  177. Trabert B, Graubard BI, Erickson RL, Zhang Y, McGlynn KA (2013). Second to fourth digit ratio, handedness and testicular germ cell tumors. Early Hum Dev, 89(7), 463-6. (Read full article)
  178. Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Cronin KA, Sherman ME (2013). Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol, 31(17), 2146-51. (Read full article)
  179. Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G (2013). In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril, 99(5), 1189-96. (Read full article)
  180. Persson EC, Schwartz LM, Park Y, Trabert B, Hollenbeck AR, Graubard BI, Freedman ND, McGlynn KA (2013). Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomarkers Prev, 22(3), 415-21. (Read full article)
  181. Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck AR, Park Y, Brinton LA (2012). Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer, 132(2), 417-26. (Read full article)
  182. Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, Hollenbeck A, Park Y, Sherman ME, Brinton LA (2012). Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. Am J Epidemiol, 177(2), 142-51. (Read full article)
  183. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2012). Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst, 104(23), 1808-14. (Read full article)
  184. Trabert B, Graubard BI, Nyante SJ, Rifai N, Bradwin G, Platz EA, McQuillan GM, McGlynn KA (2012). Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. Cancer Causes Control, 23(12), 1881-91. (Read full article)
  185. Murphy MA, Trabert B, Yang HP, Park Y, Brinton LA, Hartge P, Sherman ME, Hollenbeck A, Wentzensen N (2012). Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review. Cancer Causes Control, 23(11), 1839-52. (Read full article)
  186. Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck A, Danforth KN, Park Y, Brinton LA (2012). Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study. Br J Cancer, 107(7), 1181-7. (Read full article)
  187. Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, Brinton LA, Hartge P, Hollenbeck A, Park Y, Wentzensen N (2011). Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer, 131(4), 938-48. (Read full article)
  188. Stang A, Trabert B, Wentzensen N, Cook MB, Rusner C, Oosterhuis JW, McGlynn KA (2012). Gonadal and extragonadal germ cell tumours in the United States, 1973-2007. Int J Androl, 35(4), 616-25. (Read full article)
  189. McGlynn KA, Trabert B (2012). Adolescent and adult risk factors for testicular cancer. Nat Rev Urol, 9(6), 339-49. (Read full article)
  190. Trabert B, Graubard BI, Erickson RL, McGlynn KA (2012). Childhood infections, orchitis and testicular germ cell tumours: a report from the STEED study and a meta-analysis of existing data. Br J Cancer, 106(7), 1331-4. (Read full article)
  191. Trabert B, Longnecker MP, Brock JW, Klebanoff MA, McGlynn KA (2011). Maternal pregnancy levels of trans-nonachlor and oxychlordane and prevalence of cryptorchidism and hypospadias in boys. Environ Health Perspect, 120(3), 478-82. (Read full article)
  192. Trabert B, Schwartz SM, Peters U, De Roos AJ, Chen C, Scholes D, Holt VL (2011). Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes. Fertil Steril, 96(6), 1401-1406.e3. (Read full article)
  193. Scholes D, Yu O, Raebel MA, Trabert B, Holt VL (2011). Improving automated case finding for ectopic pregnancy using a classification algorithm. Hum Reprod, 26(11), 3163-8. (Read full article)
  194. Trabert B, Sigurdson AJ, Sweeney AM, Amato RJ, Strom SS, McGlynn KA (2010). Baldness, acne and testicular germ cell tumours. Int J Androl, 34(4 Pt 2), e59-67. (Read full article)
  195. Trabert B, Stang A, Cook MB, Rusner C, McGlynn KA (2011). Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma. Int J Androl, 34(4 Pt 2), e274-7. (Read full article)
  196. Cook MB, Trabert B, McGlynn KA (2011). Organochlorine compounds and testicular dysgenesis syndrome: human data. Int J Androl, 34(4 Pt 2), e68-84; discussion e84-5. (Read full article)
  197. Trabert B, Longnecker MP, Graubard BI, Klebanoff MA, Stanczyk FZ, McGlynn KA (2011). Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus. Cancer Causes Control, 22(5), 689-95. (Read full article)
  198. Trabert B, Holt VL, Yu O, Van Den Eeden SK, Scholes D (2010). Population-based ectopic pregnancy trends, 1993-2007. Am J Prev Med, 40(5), 556-60. (Read full article)
  199. Trabert B, Weiss NS, Rudra CB, Scholes D, Holt VL (2011). A case-control investigation of adenomyosis: impact of control group selection on risk factor strength. Womens Health Issues, 21(2), 160-4. (Read full article)
  200. Trabert B, Sigurdson AJ, Sweeney AM, Strom SS, McGlynn KA (2010). Marijuana use and testicular germ cell tumors. Cancer, 117(4), 848-53. (Read full article)
  201. Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, OMara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, Le Marchand L, Kolonel LN, Henderson BE, Garcia-Closas M, Doherty JA, De Vivo I, Chen C, Brinton LA, Akbari MR, Australian National Endometrial Cancer Study Group, Epidemiology of Endometrial Cancer Consortium E2C2 including Trabert B, Goodman MT (2011). The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One, 6(2), e16756. (Read full article)
  202. Trabert B, Peters U, De Roos AJ, Scholes D, Holt VL (2010). Diet and risk of endometriosis in a population-based case-control study. Br J Nutr, 105(3), 459-67. (Read full article)
  203. Misra D, Strobino D, Trabert B (2010). Effects of social and psychosocial factors on risk of preterm birth in black women. Paediatr Perinat Epidemiol, 24(6), 546-54. (Read full article)
  204. Trabert B, De Roos AJ, Schwartz SM, Peters U, Scholes D, Barr DB, Holt VL (2010). Non-dioxin-like polychlorinated biphenyls and risk of endometriosis. Environ Health Perspect, 118(9), 1280-5. (Read full article)
  205. Clark NM, Janz NK, Dodge JA, Lin X, Trabert BL, Kaciroti N, Mosca L, Wheeler JR, Keteyian S (2007). Heart disease management by women: does intervention format matter? Health Educ Behav, 36(2), 394-409. (Read full article)
  206. Daling JR, Doody DR, Sun X, Trabert BL, Weiss NS, Chen C, Biggs ML, Starr JR, Dey SK, Schwartz SM (2009). Association of marijuana use and the incidence of testicular germ cell tumors. Cancer, 115, 1215-23.
  207. Trabert B, Misra DP (2006). Risk factors for bacterial vaginosis during pregnancy among African American women. Am J Obstet Gynecol, 197(5), 477.e1-8. (Read full article)
  208. Misra DP, Trabert B (2006). Vaginal douching and risk of preterm birth among African American women. Am J Obstet Gynecol, 196(2), 140.e1-8. (Read full article)
  209. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Humphrey MC, Ostrander EA (2007). Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res, 9(6), R84. (Read full article)
  210. Misra DP, Trabert B, Atherly-Trim S (2005). Variation and predictors of vaginal douching behavior. Womens Health Issues, 16(5), 275-82. (Read full article)

Book Chapter

  1. Brinton LA, Trabert B (2018). Role of estrogen and progesterone in obesity associated gynecologic cancers. In Berger N, Klopp A, Lu K (Eds.), Energy Balance and Cancer: Focus on gynecologic malignancies (13, pp. 41-61). New York: Springer International Publishing.
  2. Brinton LA, Sahasrabuddhe VV, Trabert B, Franceschi S (2017). Epidemiology of gynecologic cancers. In Chi DS, Berchuck A, Dizon DS, Yashar C (Eds.), Principles and Practice of Gynecologic Oncology (seventh edition, pp. 1-23). Philadelphia: Wolters Kluwer Health.
  3. Wentzensen N, Trabert B, Schildkraut J (2013). Ovarian cancer. In Goldman MB, Troisi R, Rexrode KM (Eds.), Women and Health (second edition, pp. 1135-45). London: Academic Press.
  4. Holt V, Trabert B, Upson K (2013). Endometriosis. In Goldman MB, Troisi R, Rexrode KM (Eds.), Women and Health (second edition, pp. 271-84). London: Academic Press.
  5. Brinton LA, Sahasrabuddhe V, Trabert B (2013). Epidemiology of gynecologic cancers. In Barakat RR, Berchuck A, Markman M, Randall ME (Eds.), Principles and Practice of Gynecologic Oncology (sixth edition, pp. 1-29). Philadelphia: Lippincott Williams & Wilkins.

Letter

  1. Torres-Gonzlez E, Lpez G, Trabert B, Argueta V, Gharzouzi E, Dean M, Orozco R (2019). High prevalence of precocious menarche in Puerto Barrios, Guatemala. [Letter to the editor]. Am J Obstet Gynecol, 221(2), 162-163. (Read full article)
  2. Michels KA, Trabert B (2018). Oral Contraceptive Progestin and Estrogen Use and Increases in Breast, Ovarian, and Endometrial Cancers-Reply. [Letter to the editor]. JAMA Oncol, 4(11), 1623-1624. (Read full article)
  3. Trabert B, Chodick G, Shalev V, Sella T, Longnecker MP, McGlynn KA (2013). Gestational diabetes and the risk of cryptorchidism and hypospadias. [Letter to the editor]. Epidemiology, 25(1), 152-3. (Read full article)
  4. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2013). Response. [Letter to the editor]. J Natl Cancer Inst, 105(9), 668- 71. (Read full article)
  5. Stang A, Trabert B, Wentzensen N, Cook MB, Rusner C, Oosterhuis JW, McGlynn KA (2012). Burden of extragonadal germ cell tumours in Europe and the United States. [Letter to the editor]. Eur J Cancer, 48(7), 1116-7. (Read full article)

Abstract

  1. Michels KA, Coburn SB, Anderson G, Brinton LA, Chen C, Falk RT, Gass ML, Geczik AM, Manson JE, Pfeiffer RM, Reding K, Sarto GE, Wentzensen N, Wild RA, Xu X, Trabert B (2021). Oral contraceptive use and postmenopausal sex steroid hormone metabolism. In: Proceedings of the AACR Virtual Special Conference: Endometrial Cancer: New Biology Driving Research and Treatment; 2020 Nov 9-10. Philadelphia (PA): AACR [Abstract]. 27(3 Supplement), Abstract nr PO029.

News & Podcasts

Huntsman Cancer Institute News